VMD — Viemed Healthcare Cashflow Statement
0.000.00%
Last trade - 00:00- $279.42m
- $267.83m
- $224.26m
- 97
- 44
- 45
- 66
Annual cashflow statement for Viemed Healthcare, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 31.5 | 9.13 | 6.22 | 10.2 | 11.4 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 12.9 | 11.7 | 14.3 | 6.77 | 5.8 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -10.2 | -13.6 | -10.1 | 7.78 | 0.355 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 35.1 | 22.5 | 27.7 | 45.2 | 39.1 |
| Capital Expenditures | -13 | -19.7 | -22.9 | -26.1 | -37.8 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 4.63 | -0.003 | -1.08 | -26 | 7.07 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -8.41 | -19.7 | -24 | -52.1 | -30.7 |
| Financing Cash Flow Items | — | — | — | — | -0.228 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -9.07 | -5.32 | -15.3 | 2.83 | -3.69 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 17.6 | -2.57 | -11.5 | -4.08 | 4.7 |